CD4 and rheumatoid arthritis: A number of studies suggested that stem cell therapy or biological therapy induced a potent population of CD4+CD25+ Treg cells in patients with RA (44); however, the deficit of nTreg cells persisted in the patients even after the treatment with anti-TNF-α (45).